Skip to main content

Table 2 Co-morbidities, clinical and cardiovascular findings among CAD Group represented as frequency (n, %)

From: Identification of a circulating microRNAs biomarker panel for non-invasive diagnosis of coronary artery disease: case–control study

Variable CAD Cases P-value
Diabetes
Diabetics 33 (45.2%) > 0.05 ns
Non-diabetics 40 (54.8%)
Hypertension
Hypertensive 32 (43.8%) > 0.05 ns
Non-hypertensive 41 (56.2%)
Ischemic heart disease
Ischemic heart disease 41 (56.2%) > 0.05 ns
Non-ischemic heart disease 31 (42.5%)
BSA 1.84 ± 0.18
Systole 127.33 ± 17.28
Diastole 81.37 ± 16.14
LVEF 46.58 ± 13.25
LVEF grade  
Normal 22 (30.14%) < 0.001***
Mild 15 (20.55%)
Moderate 24 (32.88%)
Severe 12 (16.44%)
WMSI 1.49 ± 0.44
Diastolic function  
Normal 4 (5.5%) < 0.001***
Mild 42 (57.5%)
Moderate 22 (30.1%)
Severe 5 (6.8%)
  1. ***Significant at p < 0.001; ns, nonsignificant at p > 0.05 using Chi-square test